Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
4,013
Views
7
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China

Xin Guana School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China;b Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, ChinaView further author information
,
Hongchao Lia School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China;b Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, ChinaView further author information
,
Xiaomo Xionga School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China;b Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, ChinaView further author information
,
Cike Pengc Eli Lilly China Drug Development and Medical Affairs Center, Shanghai, ChinaView further author information
,
Ning Wangc Eli Lilly China Drug Development and Medical Affairs Center, Shanghai, ChinaView further author information
,
Xiao Mac Eli Lilly China Drug Development and Medical Affairs Center, Shanghai, ChinaView further author information
&
Aixia Maa School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China;b Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 339-344 | Received 08 Oct 2020, Accepted 08 Feb 2021, Published online: 01 Mar 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tong Liu, Shuang Liu, Shangwei Guan, Yu Tai, Yao Jin & Mei Dong. (2023) Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer. Journal of Chemotherapy 35:8, pages 745-752.
Read now
Qian Zhang, Zhiqiang Wang, Jingying Wu, Zhen Zhou, Renpeng Zhou & Wei Hu. (2021) Bioequivalence and Pharmacokinetic Evaluation of Two Oral Formulations of Regorafenib: An Open-Label, Randomised, Single-Dose, Two-Period, Two-Way Crossover Clinical Trial in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Drug Design, Development and Therapy 15, pages 3277-3288.
Read now
Panagiotis Petrou. (2021) The tyranny of the SW quadrant. Journal of Medical Economics 24:1, pages 741-742.
Read now

Articles from other publishers (4)

Zixuan He, Xianqin Huang, Dingyi Chen, Guoan Wang, Yuezhen Zhu, Huangqianyu Li, Sheng Han, Luwen Shi & Xiaodong Guan. (2023) Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review. BMJ Global Health 8:11, pages e012780.
Crossref
Yin Liu, Xi Zhang, Hui-Fang Xu, Ji-Hai Shi, Yu-Qian Zhao, Ling-Bin Du, Yun-Yong Liu, Wen-Jun Wang, He-Lu Cao, Li Ma, Juan-Xiu Huang, Ji Cao, Li Li, Yan-Ping Fan, Xiao-Fen Gu, Chang-Yan Feng, Qian Zhu, Xiao-Hui Wang, Jing-Chang Du, Jian-Gong Zhang, Shao-Kai Zhang & You-Lin Qiao. (2023) Real-World Utilization, Barriers, and Factors Associated With the Targeted Treatment of Metastatic Colorectal Cancer Patients in China: A Multi-Center, Hospital-Based Survey Study. International Journal of Public Health 68.
Crossref
Fan-Jie Qu, Shuang Wu & Yan Kong. (2023) Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report. World Journal of Gastrointestinal Oncology 15:5, pages 902-909.
Crossref
Liu Liu, Zhixin Jiang, Fuming Li, Yan Wei, Jian Ming, Yi Yang, Shimeng Liu, Lizheng Shi & Yingyao Chen. (2022) Were economic evaluations well reported for the newly listed oncology drugs in China’s national reimbursement drug list. BMC Health Services Research 22:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.